Pulmonary hypertension in older children: new approaches and therapies.
Abman
Steven H
SH
Pulmonary Medicine, Pediatric Heart Lung Center, University of Colorado School of Medicine, and The Children's Hospital, 1056 E. Nineteenth Avenue, Denver, CO 80218-1088, USA. Steven.abman@uchsc.edu
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D006328:Cardiac Catheterization; D002648:Child; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D004452:Echocardiography; D065128:Endothelin Receptor Antagonists; D011464:Epoprostenol / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D007555:Isoxazoles / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D013449:Sulfonamides / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D065128:Endothelin Receptor Antagonists; D007555:Isoxazoles; D010726:Phosphodiesterase Inhibitors; D013449:Sulfonamides; D013876:Thiophenes; D011464:Epoprostenol; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human; C106276:sitaxsentan; D000077300:Bosentan